Subscribe to RSS
DOI: 10.1055/s-0030-1258016
Protecting-Group-Free Total Synthesis of Goniothalesdiol A
Publication History
Publication Date:
06 August 2010 (online)
Abstract
A concise asymmetric total synthesis of goniothalesdiol A was accomplished using protecting-group-free strategy, in which silyl-Prins cyclization was used as the key step.
Key words
goniothalesdiol A - protecting-group-free - silyl-Prins cyclization - dihydroxylation
The concept of protecting-group-free (PGF) synthesis was not extensively explored until the twenty-first century, although a number of protecting-group-free total syntheses were reported. [¹] [²] Today, organic chemists invest great enthusiasm to pursue the ‘ideal syntheses’; [³] one area that offers this prospect is to minimize the use of protecting groups in synthesis. A protection-deprotection event introduces at least two steps into a sequence, increasing costs from additional reagents and waste disposal, and generally leads to a reduced overall yield. This made the development of PGF synthesis very attractive and urgent in laboratory and industry. [4] [5]
Pyrans are widely found in both natural products and pharmaceutically active compounds, and may contribute to a wide range of biological activities. In 2006, goniothalesdiol A (Scheme [¹] , compound 1), a cis-2,6-disubstituted 3,4-dihydroxy pyran, was isolated from the stem of a southern Taiwan tree Goniothalamus amuyon by Wu and co-workers. [6] There were two independent synthetic efforts toward goniothalesdiol A reported by Yadav and Fadnavis. [7] [8] In the Yadav’s synthesis, goniothalesdiol A was achieved in 11 steps and 35.1% overall yield by using Chan alkyne reduction, Sharpless kinetic resolution and intramolecular oxy-Michael addition as key steps. [7] Fadnavis synthesized goniothalesdiol A in 22% overall yield and ten steps via stereoselective allylation, Grignard reaction, cross-metathesis and intramolecular oxy-Michael addition as key steps. [8] As part of our ongoing program towards the syntheses of bioactive pyran- and pyranone-type natural products, [9] [¹0] herein we report a concise and protecting-group-free asymmetric total synthesis of goniothalesdiol A 1, in which silyl-Prins cyclization [¹¹] was used as the key step.
Retrosynthetic analysis of 1 is briefly outlined in Scheme [¹] , which suggests that it could be obtained from 3,6-dihydro-2H-pyran ester 2 via stereoselective dihydroxylation. As for the key intermediate 2, we envisioned that it could be constructed by an intramolecular silyl-Prins reaction of (Z)-silyl-β-hydroxyenoate 3 which could be prepared from (R)-2-(chloromethyl)oxirane 4 and trimethylsilylacetylene 5.

Scheme 1 Retrosynthetic analysis for goniothalesdiol A
Synthesis of (Z)-silyl-β-hydroxyenoate 3 was initiated with commercially available (R)-2-(chloromethyl)oxirane 4. After a regioselective ring opening of epoxide 4 with trimethylsilylalkynyllithium, [¹²] homopropargyl alcohol 6 was obtained. DIBAL-H reduction [¹³] of 6 gave (Z)-homoallyl alcohol 7 which was transformed to (Z)-silyl-β-hydroxyenoate 3 by lithio orthothioformate alkylation and hydrolysis. [¹4] [¹5]

Scheme 2 Protecting-group-free total synthesis of goniothalesdiol A
With 3 in hand, the silyl-Prins reaction with benzaldehyde was employed to afford 3,6-dihydro-2H-pyran ester 2 in the presence of InBr3. [¹³] It is noteworthy that aromatic aldehydes were commonly recognized as less successful substrates in the Prins reaction as they gave a mixture of cis and trans adducts in low yields in most cases. [¹6] To our delight, utility of InBr3 as the Lewis acid led to cis/trans >9:1 DHP products in a comparable yield. After a highly stereoselective dihydroxylation reaction, [¹6b] [c] goniothalesdiol A 1 was obtained in 92% yield (Scheme [²] ), whose spectral data were in good agreement with those reported in the literature. [7] [8] [¹7]
In summary, a concise asymmetric total synthesis of goniothalesdiol A 1 was achieved in six steps and 30% overall yield. The cis-2,6-disubstituted pyran moiety was effectively constructed via silyl-Prins reaction, while C-3 and C-4 vicinal dihydroxy groups were secured by stereoselective dihydroxylation. There was no protecting group utilized in this route.
- Supporting Information for this article is available online:
- Supporting Information
Acknowledgment
We are grateful for the generous financial support by the MOST (2010CB833200) and the NSFC (20872054, 20732002).
- 1
Hoffman RW. Synthesis 2006, 3531 - 2
Baran PS.Young IS. Nat. Chem. 2009, 1: 193 - 3
Wender PA. Chem. Rev. 1996, 96: 1 - 4
Green TW.Wuts PG. Protective Groups in Organic Synthesis 3rd ed.: Wiley; New York: 1999. - 5
Kocienski PJ. Protective Groups 3rd ed.: Thieme; Stuttgart: 2005. - 6
Lan Y.-H.Chang F.-R.Yang Y.-L.Wu Y.-C. Chem. Pharm. Bull. 2006, 54: 1040 - 7
Yadav JS.Rami Reddy N.Harikrishna V.Subba Reddy BV. Tetrahedron Lett. 2009, 50: 1318 - 8
Venkataiah M.Somaiah P.Reddipalli G.Fadnavis NW. Tetrahedron: Asymmetry 2009, 20: 2230 - 9a
He JM.Zheng JY.Liu J.She XG.Pan XF. Org. Lett. 2006, 8: 4637 - 9b
He JM.Tang SC.Liu J.Su YP.She XG.Pan XF. Tetrahedron 2008, 64: 8797 - 9c
Wang QL.Huang QG.Chen B.Lu JP.Wang H.She XG.Pan XF. Angew. Chem. Int. Ed. 2006, 45: 3651 - 9d
Yu BX.Jiang T.Li JP.Su YP.Pan XF.She XG. Org. Lett. 2009, 11: 3442 - 10a
Zhang JY.Li Y.Wang WK.She XG.Pan XF. J. Org. Chem. 2006, 71: 2918 - 10b
Xu YF.Huo X.Li XY.Zheng HJ.She XG.Pan XF. Synlett 2008, 1665 - 10c
Su YP.Xu YF.Han JJ.Zheng JY.Qi J.Jiang T.Pan XF.She XG. J. Org. Chem. 2009, 74: 2743 - 10d
Wang XL.Wang WK.Zheng HJ.Su YP.Jiang T.He YP.She XG. Org. Lett. 2009, 11: 3136 - 10e
Zheng HJ.Zheng JY.Yu BX.Chen Q.Wang XL.He YP.Yang Z.She XG. J. Am. Chem. Soc. 2010, 132: 1788 - 11
Semeyn C.Blaauw RH.Hiemstra H.Speckamp WN. J. Org. Chem. 1997, 62: 3426 - 12a
Yamaguchi M.Hirao I. Tetrahedron Lett. 1983, 24: 391 - 12b
Subburaj K.Okamoto S.Sato F. J. Org. Chem. 2002, 67: 1024 - 13
Liu F.Loh T.-P. Org. Lett. 2007, 9: 2063 - 14
Abood NA. Synth. Commun. 1993, 23: 811 - 15a
Mukayama T.Narasaka K.Furusato M. J. Am. Chem. Soc. 1972, 94: 8641 - 15b
Dondoni A.Marra A.Perrone D. J. Org. Chem. 1993, 58: 275 - 16a
Dobbs AP.Martinovic S. Tetrahedron Lett. 2002, 43: 7055 - 16b
Dobbs AP.Guesne SJJ.Martinovic S.Coles SJ.Hursthouse MB. J. Org. Chem. 2003, 68: 7880 - 16c
Dobbs AP.Parker RJ.Skidmore J. Tetrahedron Lett. 2008, 49: 827
References and Notes
Goniothalesdiol A (1): powder; [α]D ²5 -21.0 (c = 0.2, CHCl3). IR (KBr): 700, 758, 1047, 1078, 1170, 1203, 1438, 1735, 2920, 2952, 3425 cm-¹. ¹H NMR (400 MHz, CDCl3): δ = 1.77 (td, J = 2.4, 14.0 Hz, 1 H), 1.94 (br s, 1 H), 2.08 (ddd, J = 2.0, 3.0, 14.0 Hz, 1 H), 2.47 (dd, J = 6.0, 15.2 Hz, 1 H), 2.59 (br s, 1 H), 2.63 (dd, J = 7.2, 15.2 Hz, 1 H), 3.53 (d, J = 9.6 Hz, 1 H), 3.66 (s, 3 H), 4.22 (d, J = 3.0 Hz, 1 H), 4.41 (m, 1 H), 4.55 (d, J = 9.6 Hz, 1 H), 7.31-7.41 (m, 5 H). ¹³C NMR (100 MHz, CDCl3): δ = 37.1, 40.5, 51.7, 67.1, 68.5, 72.7, 77.8, 127.4, 128.3, 128.6, 139.2, 171.3. HRMS (ESI): m/z [M + NH4]+ calcd for C14H22NO5: 284.1492; found: 284.1488.
- 1
Hoffman RW. Synthesis 2006, 3531 - 2
Baran PS.Young IS. Nat. Chem. 2009, 1: 193 - 3
Wender PA. Chem. Rev. 1996, 96: 1 - 4
Green TW.Wuts PG. Protective Groups in Organic Synthesis 3rd ed.: Wiley; New York: 1999. - 5
Kocienski PJ. Protective Groups 3rd ed.: Thieme; Stuttgart: 2005. - 6
Lan Y.-H.Chang F.-R.Yang Y.-L.Wu Y.-C. Chem. Pharm. Bull. 2006, 54: 1040 - 7
Yadav JS.Rami Reddy N.Harikrishna V.Subba Reddy BV. Tetrahedron Lett. 2009, 50: 1318 - 8
Venkataiah M.Somaiah P.Reddipalli G.Fadnavis NW. Tetrahedron: Asymmetry 2009, 20: 2230 - 9a
He JM.Zheng JY.Liu J.She XG.Pan XF. Org. Lett. 2006, 8: 4637 - 9b
He JM.Tang SC.Liu J.Su YP.She XG.Pan XF. Tetrahedron 2008, 64: 8797 - 9c
Wang QL.Huang QG.Chen B.Lu JP.Wang H.She XG.Pan XF. Angew. Chem. Int. Ed. 2006, 45: 3651 - 9d
Yu BX.Jiang T.Li JP.Su YP.Pan XF.She XG. Org. Lett. 2009, 11: 3442 - 10a
Zhang JY.Li Y.Wang WK.She XG.Pan XF. J. Org. Chem. 2006, 71: 2918 - 10b
Xu YF.Huo X.Li XY.Zheng HJ.She XG.Pan XF. Synlett 2008, 1665 - 10c
Su YP.Xu YF.Han JJ.Zheng JY.Qi J.Jiang T.Pan XF.She XG. J. Org. Chem. 2009, 74: 2743 - 10d
Wang XL.Wang WK.Zheng HJ.Su YP.Jiang T.He YP.She XG. Org. Lett. 2009, 11: 3136 - 10e
Zheng HJ.Zheng JY.Yu BX.Chen Q.Wang XL.He YP.Yang Z.She XG. J. Am. Chem. Soc. 2010, 132: 1788 - 11
Semeyn C.Blaauw RH.Hiemstra H.Speckamp WN. J. Org. Chem. 1997, 62: 3426 - 12a
Yamaguchi M.Hirao I. Tetrahedron Lett. 1983, 24: 391 - 12b
Subburaj K.Okamoto S.Sato F. J. Org. Chem. 2002, 67: 1024 - 13
Liu F.Loh T.-P. Org. Lett. 2007, 9: 2063 - 14
Abood NA. Synth. Commun. 1993, 23: 811 - 15a
Mukayama T.Narasaka K.Furusato M. J. Am. Chem. Soc. 1972, 94: 8641 - 15b
Dondoni A.Marra A.Perrone D. J. Org. Chem. 1993, 58: 275 - 16a
Dobbs AP.Martinovic S. Tetrahedron Lett. 2002, 43: 7055 - 16b
Dobbs AP.Guesne SJJ.Martinovic S.Coles SJ.Hursthouse MB. J. Org. Chem. 2003, 68: 7880 - 16c
Dobbs AP.Parker RJ.Skidmore J. Tetrahedron Lett. 2008, 49: 827
References and Notes
Goniothalesdiol A (1): powder; [α]D ²5 -21.0 (c = 0.2, CHCl3). IR (KBr): 700, 758, 1047, 1078, 1170, 1203, 1438, 1735, 2920, 2952, 3425 cm-¹. ¹H NMR (400 MHz, CDCl3): δ = 1.77 (td, J = 2.4, 14.0 Hz, 1 H), 1.94 (br s, 1 H), 2.08 (ddd, J = 2.0, 3.0, 14.0 Hz, 1 H), 2.47 (dd, J = 6.0, 15.2 Hz, 1 H), 2.59 (br s, 1 H), 2.63 (dd, J = 7.2, 15.2 Hz, 1 H), 3.53 (d, J = 9.6 Hz, 1 H), 3.66 (s, 3 H), 4.22 (d, J = 3.0 Hz, 1 H), 4.41 (m, 1 H), 4.55 (d, J = 9.6 Hz, 1 H), 7.31-7.41 (m, 5 H). ¹³C NMR (100 MHz, CDCl3): δ = 37.1, 40.5, 51.7, 67.1, 68.5, 72.7, 77.8, 127.4, 128.3, 128.6, 139.2, 171.3. HRMS (ESI): m/z [M + NH4]+ calcd for C14H22NO5: 284.1492; found: 284.1488.

Scheme 1 Retrosynthetic analysis for goniothalesdiol A

Scheme 2 Protecting-group-free total synthesis of goniothalesdiol A